AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, J. K.
Right arrow Articles by Castillo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, J. K.
Right arrow Articles by Castillo, M.

ARTICLE

Effects of Contrast Material on Single-volume Proton MR Spectroscopy

J. Keith Smith,a, Lester Kwocka and Mauricio Castilloa

a From the Department of Radiology, CB 7510, University of North Carolina School of Medicine, Chapel Hill, NC 27599.

BACKGROUND AND PURPOSE: Administration of contrast material before proton MR spectroscopy may allow more accurate placement of the volume of interest, particularly in tumors; yet, some data have suggested that contrast material may alter the results of MR spectroscopy. To determine the validity of this contention, we performed pre- and postcontrast MR spectroscopy in patients with brain tumors and compared the results with those obtained from a phantom.

METHODS: Ten patients with astrocytomas were examined with single-volume MR spectroscopy before and after administration of contrast material. Voxel placement was identical for all studies. Peak area, peak height, and width at half maximum were measured for N-acetyl aspartate (NAA), creatine (Cr), and choline (Cho) in all studies. A phantom containing a 10-mmol concentration of NAA, Cr, and Cho was prepared in phosphate-buffered saline and mixed with contrast concentrations varying from 0.1 to 1.0 mmol. The phantom was studied by MR spectroscopy with the same parameters as used for the clinical studies.

RESULTS: No significant differences were found between the pre- and postcontrast MR spectroscopy studies for the three parameters measured. In phantom studies, there was a significant decline in the Cho peak area and height and an increase in the width at half maximum as the concentration of contrast material increased from 0.1 to 1.0 mmol. NAA and Cr peaks showed no significant changes in peak height or area.

CONCLUSION: Contrast material may be administered before clinical MR spectroscopy without affecting its interpretation.




This article has been cited by other articles:


Home page
Neuro OncologyHome page
Y. Kato, D. A. Holm, B. Okollie, and D. Artemov
Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy
Neuro Oncology, October 20, 2009; (2009) nop006v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. V. Spampinato, J. K. Smith, L. Kwock, M. Ewend, J. D. Grimme, D. L. A. Camacho, and M. Castillo
Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial Tumors
Am. J. Roentgenol., January 1, 2007; 188(1): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag
Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging
AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. M. Saindane, S. Cha, M. Law, X. Xue, E. A. Knopp, and D. Zagzag
Proton MR Spectroscopy of Tumefactive Demyelinating Lesions
AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1378 - 1386.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
I. Mader, U. Seeger, R. Weissert, U. Klose, T. Naegele, A. Melms, and W. Grodd
Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis
Brain, May 1, 2001; 124(5): 953 - 961.
[Abstract] [Full Text] [PDF]